Welcome, Guest. Please login or register.
April 20, 2024, 07:15:09 am

Login with username, password and session length


Members
  • Total Members: 6307
  • Latest: golfer
Stats
  • Total Posts: 55126
  • Total Topics: 4851
  • Online Today: 87
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 76
Total: 76

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: FDA Grants Priority Review for New Hepatitis C Drugs  (Read 25561 times)

0 Members and 1 Guest are viewing this topic.

Offline lporterrn

  • Member
  • Posts: 1,969
  • LucindaPorterRN
    • LucindaPorterRN
FDA Grants Priority Review for New Hepatitis C Drugs
« on: January 05, 2016, 05:33:12 pm »
Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir/Velpatasvir for Treatment of All Genotypes of Chronic Hepatitis C Infection

-- Final FDA Decision Anticipated by  June 28, 2016  --

FOSTER CITY, Calif. --(BUSINESS WIRE)--Jan. 4, 2016--  Gilead Sciences, Inc.  (Nasdaq: GILD) today announced that the  U.S. Food and Drug Administration  ( FDA ) has granted priority review to the company’s New Drug Application (NDA) for an investigational, once-daily fixed-dose combination of the nucleotide analog polymerase inhibitor sofosbuvir (SOF), approved as Sovaldi® in  December 2013 , and velpatasvir (VEL), an investigational pan-genotypic NS5A inhibitor, for the treatment of chronic genotype 1-6 hepatitis C virus (HCV) infection. Gilead filed the NDA for SOF/VEL on  October 28, 2015 , and  FDA  has set a target action date under the Prescription Drug User Fee Act (PDUFA) of  June 28, 2016 .

The  FDA  has assigned SOF/VEL a Breakthrough Therapy designation, which is granted to investigational medicines that may offer major advances in treatment over existing options. The NDA for SOF/VEL is supported by data from four Phase 3 ASTRAL trials, which evaluated the fixed-dose combination in hepatitis C genotypes 1-6. A marketing application for SOF/VEL is also under review in the  European Union , and was validated by the  European Medicines Agency  (EMA) in December. The SOF/VEL fixed-dose combination is an investigational product and its safety and efficacy have not been established.
Lucinda Porter, RN
1988 Contracted HCV
1997 Interferon nonresponder
2003 PEG + ribavirin responder-relapser
2013 Cured (Harvoni + ribavirin clinical trial)
https://www.hepmag.com/blogger/lucindakporter

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #1 on: January 25, 2016, 10:52:41 am »
Lucinda, Believe this is the study that I am in. You can PM if you want to know more.
Hopefully this drug will work


Fight the Good Fight !!
John
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline lporterrn

  • Member
  • Posts: 1,969
  • LucindaPorterRN
    • LucindaPorterRN
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #2 on: January 25, 2016, 11:54:08 am »
Hope you let us know how it goes. Info from clinical trial subjects is very helpful for those who are looking ahead to other treatments, Good luck.
Lucinda Porter, RN
1988 Contracted HCV
1997 Interferon nonresponder
2003 PEG + ribavirin responder-relapser
2013 Cured (Harvoni + ribavirin clinical trial)
https://www.hepmag.com/blogger/lucindakporter

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #3 on: January 25, 2016, 12:16:20 pm »
I will. Thursday is the start of meds, 12 weeks and follow ups. Really exciting stuff.

John
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #4 on: February 08, 2016, 11:36:35 pm »
I needed to have a Fibroscan before treatment with the study could begin. Everything is a go, waiting to get my meds. The study is SOF/VEL GS-9857. My understanding is that this will hopefully be the drug that gets the job done
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline lporterrn

  • Member
  • Posts: 1,969
  • LucindaPorterRN
    • LucindaPorterRN
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #5 on: February 09, 2016, 04:36:24 pm »
So this study uses an additional drug, and isn't one of the ones under priority review. I assume this study has various arms with various combinations and durations of treatment? Let us know when you start what you are taking and for how long. Good luck!
Lucinda Porter, RN
1988 Contracted HCV
1997 Interferon nonresponder
2003 PEG + ribavirin responder-relapser
2013 Cured (Harvoni + ribavirin clinical trial)
https://www.hepmag.com/blogger/lucindakporter

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
« Last Edit: February 10, 2016, 01:33:47 am by HHburme »
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline lporterrn

  • Member
  • Posts: 1,969
  • LucindaPorterRN
    • LucindaPorterRN
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #7 on: February 10, 2016, 05:54:37 pm »
Are you in the 3 drug or 2 drug arm? When I did clinical trials, no one knew which arm they'd be in (including the nurse and doc) until the day the patient arrived to begin the drug. However, in this case, either arm is great.
Lucinda Porter, RN
1988 Contracted HCV
1997 Interferon nonresponder
2003 PEG + ribavirin responder-relapser
2013 Cured (Harvoni + ribavirin clinical trial)
https://www.hepmag.com/blogger/lucindakporter

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #8 on: February 11, 2016, 09:39:21 am »
LP, The study is the for Gileads latest trial drug with three medicines, SOF/VEL and a third drug GS-9857. This will treat all genotypes as well as RAV. I'm geno 1A so there is a 50% chance that initially I will receive a placebo. If I do, then after 12 weeks I will be given the real drug. This is only for geno type 1. All other geno in the study will given the drug at the the start. I was told this drug is believed to be the answer to all types of HCV. So, no matter what geno, whether you are resistant(RAV), treatment experienced or naïve, Cirrhotic or not, this drug will work. All are 12 week treatments. The anticipated approval date is next January. I am resistant, NS5A and one of the few that Harvoni did not work on and my Hepatologist is very, very confident this will work on me.
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline beto

  • Member
  • Posts: 548
  • "no risk it, no biscuit"
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #9 on: February 11, 2016, 01:28:58 pm »
so cool HH...congrats.  Let's hope for the real McCoy.  Either way, life is good.  peace
HCV/nonA,nonB acute phase 1975
HCV detected active 1990
HCV persistent chronic diagnosis 1995
1995 liver enzymes mild elevations
1996 Biopsy F2 fibrosis
treatment naive geno 1-A
2000-to early 2015 Viral load 150, 000 to 800, 000
recent liver enzymes before treatment alt/ast 59to209,  Fibroscan F4,cirrhosis
start tx Harvoni 7/11/2015
6.5 week-UD-ast/alt 25/25
9wk-UD-ast18 alt23
10/3/15 completed tx
11/5/15 new fibroscan f0-f1 amazed
6wk EOT UD ast/alt 20/20
12EOT-UD-ast/alt19/21
25wk-SVR! 19/18

Offline lporterrn

  • Member
  • Posts: 1,969
  • LucindaPorterRN
    • LucindaPorterRN
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #10 on: February 11, 2016, 03:52:16 pm »
You have such a good chance. In the ASTRAL-1 study, SVR rates for GT 1a were 99%  with sof/vel, so even if you don't get the 3rd drug, you'd have to have very bad luck to not clear. Among those with RAVs, the SVR was 99%. Knock 'em dead!
Lucinda Porter, RN
1988 Contracted HCV
1997 Interferon nonresponder
2003 PEG + ribavirin responder-relapser
2013 Cured (Harvoni + ribavirin clinical trial)
https://www.hepmag.com/blogger/lucindakporter

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #11 on: February 11, 2016, 04:25:56 pm »
HHburme, keep us posted!!  Prayers are with you........ FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

Offline Else

  • Member
  • Posts: 523
  • Appeal, appeal, and appeal again!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #12 on: February 12, 2016, 04:04:07 pm »
That sounds really promising, HH!  And it sounds like you have a hepatologist who stays very current in HCV treatments and breakthroughs.  That is awesome!
F/53 yr
diagnosed 1995
Genotype 1a
ALT: 58 AST: 39 ALK: 105
Viral load 4,201,950 IU/ml
Fibroscan 6.5 (F1-F2) Fibrosure 0.36 (F1-F2)
Treatment-naive
After 3 denials, finally approved!
Harvoni 12 wks - start date 9/15/15
4 wk labs 10/14/15
ALT: 12 AST: 16 ALK: 85
HCV Not Detected!!!
8 wk labs 11/10/15
ALT: 13  AST: 15  ALK: 77
12 wk (EOT!) labs 12/8/15
ALT: 11 AST: 15 ALK: 78
HCV Not Detected!!!
10wk posttx labs 2/11/16
ALT: 22 AST: 17 ALK: 61
HCV Not Detected!! SVR10!!!
SVR10 (99.7% Cured!!!)

Offline Mike

  • Member
  • Posts: 999
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #13 on: February 14, 2016, 01:58:47 pm »
Hi HHburme,

This is such great news! I'm glad you got in the trial and thanks for blazing the trial!

Best wishes, Mike
Genotype 1a
Treated 2001 with PEG and RIBV
Treated in 2014 SOL+PEG+RIBV
Cured July 2014

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #14 on: February 17, 2016, 12:12:17 pm »
Took my first pill yesterday. I will take for 84 days, every 24 hours, and hopefully this new three headed pill can slay the dragon. I go once a week for labs, exams, during the first month. Then monthly until finished. I will not know any lab results, as this is a double blinded study, until completion. This drug has tremendous potential to work, with little or no SE, much like Harvoni . It's really exciting, for me, to be involved with the Gilead researchers and the University medical team, to help find a cure for Hep C that will help everyone in the world be free from this disease. Worldwide there are only 320 people in this study. If all goes well, should be approved by as early January 2017. I feel truly blessed. I have always said "everything happens for a reason" and maybe that's why I failed Harvoni.

Fight the Good Fight
John
« Last Edit: February 17, 2016, 12:21:45 pm by HHburme »
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #15 on: February 17, 2016, 12:54:21 pm »
HHburme -- I totally agree with you in that "everything happens for a reason" and that there truly is HOPE and a lot of it, for all with this disease! It is amazing how much new data has exploded over the past 18 months. Thank you for blazing the trail w/ this trial for those who relapse on Harvoni.  It's my biggest fear now, since I've finally gotten the OK from IMR to start Harvoni -- pills should be here in the next 2-3 days. Excited and anxious at the same time. Best of luck to you on this trial and keep us posted -- The future is bright!!  FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #16 on: February 23, 2016, 02:45:48 pm »
Finished first week with no side effects, had tests and labs today.


John
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline Else

  • Member
  • Posts: 523
  • Appeal, appeal, and appeal again!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #17 on: February 23, 2016, 03:31:08 pm »
Best to you, HH.  Everyone here is cheering you on!!!
F/53 yr
diagnosed 1995
Genotype 1a
ALT: 58 AST: 39 ALK: 105
Viral load 4,201,950 IU/ml
Fibroscan 6.5 (F1-F2) Fibrosure 0.36 (F1-F2)
Treatment-naive
After 3 denials, finally approved!
Harvoni 12 wks - start date 9/15/15
4 wk labs 10/14/15
ALT: 12 AST: 16 ALK: 85
HCV Not Detected!!!
8 wk labs 11/10/15
ALT: 13  AST: 15  ALK: 77
12 wk (EOT!) labs 12/8/15
ALT: 11 AST: 15 ALK: 78
HCV Not Detected!!!
10wk posttx labs 2/11/16
ALT: 22 AST: 17 ALK: 61
HCV Not Detected!! SVR10!!!
SVR10 (99.7% Cured!!!)

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #18 on: February 24, 2016, 09:49:57 am »
This is the correct info for the study that I'm participating with Gilead. The link is www.clinicaltrials.gov and enter the study number GS-US-367-1171 . It is the POLARIS 1 arm, studying relapsers of Harvoni.

John
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline northfork

  • Member
  • Posts: 57
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #19 on: February 28, 2016, 11:31:23 am »
Lucinda, I am testing for the Polaris -1 trial also. Had initial labs and a fibrotest( f-2) but they want a fibroscan also. So I will have that and see. I checked on a Merk 3 drug trial, but it was phase2 and the side effects for just the first drug in that cocktail were pretty horrible, so I declined.

HH Burme is leading the way.

Best to all.


Probably infected 1969. Diagnosed 2006. Genotype 1b.
Daclatasvir/ Asunaprevir 2013:relapse
Harvoni 24 weeks 2015:relapse
sofosbuvir, velpatisvir, voxillaprevir  trial started on drug 7/16. Viral load 890,000 approx. F2. Undetected after week 1.
12 week SVR achieved Jan 2017.
SVR 24 achieved April 2017 !

60 weeks post treatment...UNDETECTED!

Offline lporterrn

  • Member
  • Posts: 1,969
  • LucindaPorterRN
    • LucindaPorterRN
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #20 on: February 28, 2016, 02:24:07 pm »
We need a "fingers-crossed" emoticon. Good luck!
Lucinda Porter, RN
1988 Contracted HCV
1997 Interferon nonresponder
2003 PEG + ribavirin responder-relapser
2013 Cured (Harvoni + ribavirin clinical trial)
https://www.hepmag.com/blogger/lucindakporter

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #21 on: March 01, 2016, 06:25:54 pm »
Northfork, I hope you get in !!!! Took my 15th pill today and no SE at all.
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline northfork

  • Member
  • Posts: 57
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #22 on: March 01, 2016, 08:24:54 pm »
Starting next week, H.H. Hope this tames our frankenviruses. :D I can't help but think there is a lot more to learn about this disease. If this doesn't do the trick, maybe technology will advance to where they can print me a new liver on a 3D printer if I need one. i guess they have done ears already.

Keep up the fight.
Probably infected 1969. Diagnosed 2006. Genotype 1b.
Daclatasvir/ Asunaprevir 2013:relapse
Harvoni 24 weeks 2015:relapse
sofosbuvir, velpatisvir, voxillaprevir  trial started on drug 7/16. Viral load 890,000 approx. F2. Undetected after week 1.
12 week SVR achieved Jan 2017.
SVR 24 achieved April 2017 !

60 weeks post treatment...UNDETECTED!

Offline gnatcatcher

  • Member
  • Posts: 1,372
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #23 on: March 01, 2016, 09:41:36 pm »
… If this doesn't do the trick, maybe technology will advance to where they can print me a new liver on a 3D printer if I need one. i guess they have done ears already....

Ears -- and now ravioli, crackers, chicken nuggets, and more:
http://hosted.ap.org/dynamic/stories/E/EU_TEC_WIRELESS_SHOW_THE_QUIRKY?SITE=AP&SECTION=HOME&TEMPLATE=DEFAULT&CTIME=2016-02-23-13-41-51
They'd better come up with a way to print a new liver, to deal with the astronomical gastronomical onslaught.

Best of luck to you guys!

Gnatty
9/29/71 transfusions
HCV genotype 1a
7/09/15-9/30/15 Harvoni

Before treatment:
Viral Load 9,490,582
FibroScan 19.5 kPa [F4]
ALT 262
AST 217
ALP 183

Most recent:
VL still UNDETECTED (SVR 102)
FibroScan 7.6 kPa [F1-2]
ALT 15
AST 20
ALP 85

Offline Philadelphia

  • Global Moderator
  • Member
  • Posts: 1,157
  • It only looks like I know what I'm doing
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #24 on: March 05, 2016, 07:59:33 pm »
I'm pretty sure that one or one very like it was something my specialist had me tagged for if I had failed my DAA treatment. I know it was a Gilead study for people who had not cleared via the new DAAs. Good luck!
CURED SVR24  Class of 2015
Wk 12 post EOT 30.11.15: ALT 14 AST 22 GGT 22 VL UND
Week 19 07.08.15: ALT 17 AST 23 GGT 25
Week 12 18.06.15: ALT 21 AST 23 GGT 28
Week 8 25.05.15: ALT 23 AST 27 GGT 30 VL UND
Week 4 20.04.14: ALT 30 AST 36 VL 40
Treatment start 23.03.15: ALT 137 AST 185 VL 342,600
Cirrhosis Child-Pugh A, Genotype 1a - Viekira Pak + riba 24 weeks
Total failure interferon/ribavirin/boceprovir Mar 2013
https://www.hepmag.com/blogger/grace-campbell

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #25 on: April 26, 2016, 11:41:00 pm »
Finished my 10th week of the study, 2 more to go. My liver enzyme tests have been in normal range. The VL labs are blind to me and my Dr., with a 50% chance of being on a placebo. Only other times my AST & ALT were normal was while taking Harvoni. So I think that I may be on the real drug. I will know in a few weeks.
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #27 on: April 27, 2016, 12:37:25 pm »
So exciting, please keep us posted! Pleased to hear the SE have been so minimal.  You and I are finishing our treatments very near the same day -- my last Harvoni pill will be on May 17th, which sounds close to your last date.  You are making an extremely valuable contribution to the body of knowledge on this difficult-to-cure disease, for which we are all very grateful! The future is bright -- FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

Offline morab

  • Member
  • Posts: 232
  • Lives in the woods
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #28 on: May 14, 2016, 01:48:58 pm »
This is very exciting news.
I will continue to follow your progress!
Hang in there HH and keep us posted
Morab
3/2016 G 1a
Alt 84
Ast 62
Fibrosis score lab 0.66
quantitation 894,670
4/23/16 day 6, naive Harvoni 12 week treatment
5/27/16 week 4 lab results UNDETECTED AST 23 ALT17

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #29 on: May 14, 2016, 04:50:34 pm »
Finished 12 week clinical trial last Monday. Had labs drawn on Tuesday and going to see Dr in 4 weeks, hopefully get some answers then. Feeling good.
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #30 on: May 15, 2016, 05:51:43 pm »
Please keep us posted! FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #31 on: June 08, 2016, 10:13:49 am »
Going today for 4 week post treatment clinical trial follow up. Should get the news if I was taking real drug SOF/VEL GS-9857 or placebo. Hoping for the best !

John
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline Rosie13

  • Member
  • Posts: 297
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #32 on: June 08, 2016, 05:13:35 pm »
HH, you are so inspiring! I get the goosies reading your posts. I know this will cure you ...feelin' it in Florida!
Labs August 15,2015
Genotype 1b
AST 112 U/L
ALT 181 U/L
HCV 192,000 IU/mL
Fibroscan F2-3
Started Harvoni Sept. 5, 2015
4wk. labs Oct. 2,2015
AST 21 U/L
ALT 27 U/L
HCV UNDETECTED!!
8wk. labs Nov.5,2015
AST 16 U/L
ALT 19 U/L
HCV UNDETECTED!!
12 wks.post tx.feb.11,2016
UNDETECTED!!!
24 wks. post tx. may 16,2016
UNDETECTED Fibroscan  F-0!!!!!

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #33 on: June 20, 2016, 11:17:13 am »
Hi Everyone !!  4 week post treatment labs came in. I was on the REAL drug, not placebo. I am NEGATIVE 4 weeks after stopping treatment!!!!!


John
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline lporterrn

  • Member
  • Posts: 1,969
  • LucindaPorterRN
    • LucindaPorterRN
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #34 on: June 20, 2016, 11:55:46 am »
Fantastic!!!!
Lucinda Porter, RN
1988 Contracted HCV
1997 Interferon nonresponder
2003 PEG + ribavirin responder-relapser
2013 Cured (Harvoni + ribavirin clinical trial)
https://www.hepmag.com/blogger/lucindakporter

Offline KimInTheForest

  • Member
  • Posts: 1,972
  • Believe in yourself
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #35 on: June 20, 2016, 03:43:10 pm »
Wonderful news, John! Congrats! :)

kim
Kim Goldberg (Nanaimo, BC)
1970s: Contracted HCV (genotype 3a)
2015: Cured with Harvoni + ribavirin (12 weeks)
MY STORY: https://pigsquash.wordpress.com/2016/01/28/undetectable-my-hep-c-story/

Offline Rosie13

  • Member
  • Posts: 297
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #36 on: June 20, 2016, 04:51:04 pm »
HH, seems a conga line is forming for our newest freedom fighter! Congrats on testing what will be another breathtaking advance for this disease. So Exciting!
Labs August 15,2015
Genotype 1b
AST 112 U/L
ALT 181 U/L
HCV 192,000 IU/mL
Fibroscan F2-3
Started Harvoni Sept. 5, 2015
4wk. labs Oct. 2,2015
AST 21 U/L
ALT 27 U/L
HCV UNDETECTED!!
8wk. labs Nov.5,2015
AST 16 U/L
ALT 19 U/L
HCV UNDETECTED!!
12 wks.post tx.feb.11,2016
UNDETECTED!!!
24 wks. post tx. may 16,2016
UNDETECTED Fibroscan  F-0!!!!!

Offline morab

  • Member
  • Posts: 232
  • Lives in the woods
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #37 on: June 20, 2016, 05:03:19 pm »
HH
This is some of the most awesome news I have heard in a long time.
Thank you so much for being so brave for those that come behind you for tx.
Congratulations!
Morab
3/2016 G 1a
Alt 84
Ast 62
Fibrosis score lab 0.66
quantitation 894,670
4/23/16 day 6, naive Harvoni 12 week treatment
5/27/16 week 4 lab results UNDETECTED AST 23 ALT17

Offline kimlav

  • Member
  • Posts: 24
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #38 on: June 21, 2016, 09:44:56 am »
Wow John that is fantastic news! That is the drug I was planning on should Harvoni have failed me which thankfully is not the case.

Yay for you!

Kim
52 year old female
Geno 1a
Contracted in the 80's
Tx naive
vl 657,000 in Nov/15
No liver damage
ALT prior to tx: 107, 91 - 41 at 2 wks, 38 at 4 wks
AST prior to tx: 59,72 - 45 at 2 wks, 37 at 4 wks
started 8 wks Harvoni on Jan 21/16
EOT vl <12 detected
4.5 wk EOT vl - target not detected! RNA Not detected!
12 wk EOT vl - target not detected! (Will never get tired of typing that)
24 wk EOT vl -  not detected

Offline brie41

  • Member
  • Posts: 191
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #39 on: June 22, 2016, 08:39:07 pm »
Hi John,

  Great news, so happy for you!!!  Brie
Diagnosed  HCV, 1A 2006
Viral load 6 million
Ast/Alt always in the 20's
F0-F1, never changed
Treatment naive, started 8 week Harvoni 3/15/16
4 and 8 week labs undetected
6 week eot labs undetected
13 week eot UNDETECTED!

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #40 on: June 25, 2016, 10:13:46 am »
Thanks everyone!! It's been a hell of a rollercoaster ride !!! Feel so fortunate to have been asked to participate in this clinical study and hope that this may be a cure for everybody with hcv. I am scheduled for my 12 week post treatment labs in six weeks. Feel great!!

Fight the good fight!!!

John
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline Rosie13

  • Member
  • Posts: 297
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #41 on: June 25, 2016, 11:32:58 am »
Hey John, 6 wks. left to confirm what we feel! You got it done & now thousands will take this next step & it is just amazing! The Harvoni commercials have been modified to say " over a quarter of a million" have been treated with success...now that number should sky rocket. I still get a surreal feeling when I remember we were untreatable just a short time ago. So happy for you!
Labs August 15,2015
Genotype 1b
AST 112 U/L
ALT 181 U/L
HCV 192,000 IU/mL
Fibroscan F2-3
Started Harvoni Sept. 5, 2015
4wk. labs Oct. 2,2015
AST 21 U/L
ALT 27 U/L
HCV UNDETECTED!!
8wk. labs Nov.5,2015
AST 16 U/L
ALT 19 U/L
HCV UNDETECTED!!
12 wks.post tx.feb.11,2016
UNDETECTED!!!
24 wks. post tx. may 16,2016
UNDETECTED Fibroscan  F-0!!!!!

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #42 on: June 25, 2016, 12:14:02 pm »
Excellent news, John and yes -- we are all fighting the good fight!!!!  Keep us posted on this very important issue, FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #43 on: August 16, 2016, 12:10:37 pm »
Just got the call. UNDETECTED !!!!  SVR 12.  Na Na Na....Na Na Na....Hey Hey Hey.......GOODBYE !!!! Feels so great to finally join the winning team and post that I made it !! Thanks to Gilead and my team of Doctors for helping me. I believe this drug will end HCV. Feel so blessed to have participated in this clinical trial study. To everyone that relapsed or still waiting for treatment, THIS is the drug !!

Fight the Good Fight !
John
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline KimInTheForest

  • Member
  • Posts: 1,972
  • Believe in yourself
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #44 on: August 16, 2016, 12:24:19 pm »
CONGRATS JOHN !!! You made it!  8)

kim
Kim Goldberg (Nanaimo, BC)
1970s: Contracted HCV (genotype 3a)
2015: Cured with Harvoni + ribavirin (12 weeks)
MY STORY: https://pigsquash.wordpress.com/2016/01/28/undetectable-my-hep-c-story/

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #45 on: August 16, 2016, 12:29:47 pm »
Thank You Kim !!!!!     I feel GREAT !!
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #46 on: August 16, 2016, 02:40:51 pm »
HHburme -- WAY TO GO!!!!!!!  You must feel on cloud 9!!!!  I will find out if I have reached SVR12 on Monday, so I will hopefully be able to post news as great as yours.
Enjoy!!!  The future is very bright, FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

Offline Rosie13

  • Member
  • Posts: 297
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #47 on: August 16, 2016, 04:29:51 pm »
JoHN!Your exciting post gave me the chills.the good kind!So happy for you..
Labs August 15,2015
Genotype 1b
AST 112 U/L
ALT 181 U/L
HCV 192,000 IU/mL
Fibroscan F2-3
Started Harvoni Sept. 5, 2015
4wk. labs Oct. 2,2015
AST 21 U/L
ALT 27 U/L
HCV UNDETECTED!!
8wk. labs Nov.5,2015
AST 16 U/L
ALT 19 U/L
HCV UNDETECTED!!
12 wks.post tx.feb.11,2016
UNDETECTED!!!
24 wks. post tx. may 16,2016
UNDETECTED Fibroscan  F-0!!!!!

Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #48 on: August 16, 2016, 05:38:08 pm »
FT, confident you're joining me in the SVR12 club with the others. Rosey....thank you for all your support!! So Happy !!!
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: FDA Grants Priority Review for New Hepatitis C Drugs
« Reply #49 on: August 16, 2016, 07:32:14 pm »
HH, I have to tell you that your trial and your results certainly ease some of the stress for those of us who are in the final days of reaching or not reaching SVR12.  And for that I am very grateful.  Be proud that you've contributed some very valuable data towards the eradication of this beast.  FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.